SupPro Botox: Dynamic Splinting for Excessive Pronation Following CVA

Sponsor
Dynasplint Systems, Inc. (Industry)
Overall Status
Withdrawn
CT.gov ID
NCT00900692
Collaborator
(none)
0
1
2
89
0

Study Details

Study Description

Brief Summary

The purpose of this study is to examine range of motion and lasting effects of Botox injections along with the use of the Supination Dynasplint.

Condition or Disease Intervention/Treatment Phase
  • Device: Dynasplint
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Dynamic Splinting for Excessive Pronation Following CVA: A Randomized, Controlled Tial
Study Start Date :
May 1, 2009
Anticipated Primary Completion Date :
Sep 1, 2016
Anticipated Study Completion Date :
Oct 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Dynasplint Group

Along with the standard of care Botox and manual therapy, patients will use the Supination Dynasplint every day

Device: Dynasplint
Dynamic splinting utilizes the protocols of Low-Load Prolonged Stretch (LLPS) with calibrated adjustable tension to increase Total End Range Time (TERT)to reduce contracture. The Dynasplint or "Experimental" group will add this therapy to their standard of care regimen

No Intervention: Standard of care

Patients in the standard of care group will have the standard Botox treatments and manual therapy with no additional interventions.

Outcome Measures

Primary Outcome Measures

  1. ROM changes with use of treatment [20 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria

Patients enrolled will have been diagnosed with excessive pronation following a stroke and will display the following symptoms:

  • Pronation Contracture

  • Ability to provide consent and follow directions as related to the protocol

Exclusion Criteria

  • Treatment with Benzodiazepines

  • Treatment with Baclofen (pump or oral)

  • Treatment with Dantrolene sodium

  • Treatment with Tizanidine

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rehabilitation Associates of Indiana Indianapolis Indiana United States 46250

Sponsors and Collaborators

  • Dynasplint Systems, Inc.

Investigators

  • Principal Investigator: Marc E Duerden, MD, Rehabilitation Associates of Indiana

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Dynasplint Systems, Inc.
ClinicalTrials.gov Identifier:
NCT00900692
Other Study ID Numbers:
  • 2009.001
First Posted:
May 13, 2009
Last Update Posted:
Jul 11, 2013
Last Verified:
Jul 1, 2013
Keywords provided by Dynasplint Systems, Inc.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 11, 2013